tirzepatide and levocarnitine tirzepatide/levocarnitine with 𝗔 𝘀𝗺𝗮𝗿𝘁𝗲𝗿 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵! Our Tirzepatide + Levocarnitine + NAD⁺ combination supports weight management, blood sugar balance, energy production, tirzepatide 16.6 mg/levocarnitine 100 mg/ml

& Winkler, J

For all trials, subjects had a minimum HbA 1c of 7.0%, and there were no restrictions on body weight or body mass index (BMI)

GLP-1 agents, for example, reinforce the physiologic processes that slow gastric emptying and signal fullness

The mechanism of action includes several key effects: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing glucose production by the liver Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 medications are administered via subcutaneous injection , either once weekly (semaglutide, dulaglutide) or once daily (liraglutide), depending on the specific formulation

All patients were at least 45 years old and hadn't received a glucagon-like peptide-1 receptor agonist (GLP-1 RA) or sodium-glucose cotransporter-2 (SGLT-2) inhibitor in the prior year